Blood Preparation Market Size By Product (Whole Blood, Blood Components, Blood Derivatives), By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications), By Antithrombotic and Anticoagulants (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, China, Japan, Brazil, Mexico, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

Published Date: October 2016 | 168 Pages | Report ID: GMI790 Report Format: PDF

Inquiry Before Buying   Request Sample

Market segmentation

Blood preparation market by product, 2012-2024 (USD Million)

  • Whole Blood
    • Red Cells
    • Granulocytes
    • Plasma
    • Platelets
  • Blood Components
    • Whole Blood Components
    • Packed Red Cells
    • Leukocyte Reduced Red Blood Cells
    • Frozen Plasma
    • Platelet Concentrate
    • Cryoprecipitate
  • Blood Derivatives

Blood preparation market by application, 2012-2024 (USD Million)

  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications

Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)

  • Antithrombotic
    • Platelet Aggregation Inhibitors
      • Glycoprotein Inhibitors
      • COX Inhibitors
      • ADP Antagonists
      • Phosphodiesterase Inhibitors
    • Fibrinolytics
      • Tissue Plasminogen Activator (tPA)
      • Streptokinase
      • Urokinase
  • Anticoagulants
    • Heparins
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWH)
    • Ultra-low Molecular Weight Heparin
  • Vitamin K Antagonists
  • Direct Thrombin Inhibitors
  • Direct Factor Xa Inhibitors

Blood preparation market by region, 2012-2024 (USD Million)

  • North America
  • Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • U.S.
  • Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • Canada
  • Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • Europe
  • Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • UK
  •  Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • Germany
  •  Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • France
  • Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • Italy
  • Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • Asia Pacific
  • Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • China
  •  Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
      • Direct Factor Xa Inhibitors
  • Japan
  •  Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
    • Fibrinolytics
      • Tissue Plasminogen Activator (tPA)
      • Streptokinase
      • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • Latin America
  •  Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • Brazil
  •  Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • Mexico
  •  Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • MEA
  •  Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • South Africa
  • Blood preparation market by product, 2012-2024 (USD Million)
    • Whole Blood
      • Red Cells
      • Granulocytes
      • Plasma
      • Platelets
    • Blood Components
      • Whole Blood Components
      • Packed Red Cells
      • Leukocyte Reduced Red Blood Cells
      • Frozen Plasma
      • Platelet Concentrate
      • Cryoprecipitate
    • Blood Derivatives
  • Blood preparation market by application, 2012-2024 (USD Million)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Blood preparation market by antithrombotic and anticoagulants, 2012-2024 (USD Million)
    • Antithrombotic
      • Platelet Aggregation Inhibitors
        • Glycoprotein Inhibitors
        • COX Inhibitors
        • ADP Antagonists
        • Phosphodiesterase Inhibitors
      • Fibrinolytics
        • Tissue Plasminogen Activator (tPA)
        • Streptokinase
        • Urokinase
    • Anticoagulants
      • Heparins
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security

Tailor this report

Customize this report to suit your needs, speak to our research team to avail these benefits


Connect with our sales team